ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
OBJECTIVE: To assess effects of intravenous streptokinase, one month of oral aspirin, or both, on long term survival after suspected acute myocardial infarction. DESIGN: Randomised, "2 x 2 factorial," placebo controlled trial. SETTING: 417 hospitals in 16 countries. SUBJECTS: 17 187 patie...
Auteurs principaux: | Baigent, C, Collins, R, Appleby, P, Parish, S, Sleight, P, Peto, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
BMJ Publishing Group
1998
|
Documents similaires
-
ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION
par: Collins, R, et autres
Publié: (1989) -
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
par: Collins, R, et autres
Publié: (1987) -
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
par: Collins, R, et autres
Publié: (1997) -
ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
par: Collins, R, et autres
Publié: (1993) -
Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
par: Collins, R
Publié: (1987)